Loading Events

« All Events

Exploring Ethical Dilemmas: “Medicine” with Dr. Carol Portlock (Hybrid)

February 21 @ 6:30 pm - 8:00 pm

Retired Medical Oncologist Carol Portlock will lead a discussion of the ethical considerations regarding “cutting edge” treatments, drug development and cost as raised in the recent approval of Aduhelm, a new controversial therapy for Alzheimer’s Disease. Controversies in effectiveness, side effects/toxicities as well as expense will be examined. The ethics of offering the option of “no treatment“ in Alzheimer’s disease and some lymphomas will also be addressed.

References:

Aduhelm
https://www.wsj.com/articles/biogen-fda-aduhelm-alzheimers-drug-approval-11641327408
https://www.cnbc.com/2022/01/04/why-biogens-alzheimers-drug-aduhelm-is-so-controversial-.html

Lymphomas
https://cancer.ca/en/cancer-information/cancer-types/non-hodgkin-lymphoma/treatment/indolent-lymphoma

Carol Portlock, M.D. did all her undergraduate/medical training at Stanford specializing in medical oncology and participating in clinical research of chemotherapy. After moving East, Dr. Portlock worked at Yale for 10 years and at Memorial Sloan-Kettering for 30 years continuing her clinical research in lymphoma. Dr. Portlock was a member of the MSK Ethics Committee for 19 years. She retired in 2018.

Details

Date:
February 21
Time:
6:30 pm - 8:00 pm
Event Category: